Personensuche
Personensuche
Es wurde 1 Person gefunden.
Klinik für Nuklearmedizin am Universitätsklinkum Essen
Anschrift
Hufelandstr. 55
45122 Essen
45122 Essen
Funktionen
-
Nebenberuflich Lehrende/r, Klinik für Nuklearmedizin
Aktuelle Veranstaltungen
-
2024 WS
Vergangene Veranstaltungen (max. 10)
-
2024 SS
-
2023 SS
-
2022 WS
-
2022 SS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer : Analysis of the phase 3 VISION trialIn: Cancer Jg. 130 (2024) Nr. 20, S. 3426 - 3435Online Volltext: dx.doi.org/ (Open Access)
-
A VISION Substudy of Reader Agreement on ⁶⁸Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for ¹⁷⁷Lu-PSMA-617 Radioligand TherapyIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 8, S. 1259 - 1265Online Volltext: dx.doi.org/ (Open Access)
-
Health-related quality of life and pain outcomes with [¹⁷⁷Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION) : a multicentre, open-label, randomised, phase 3 trialIn: The Lancet Oncology Jg. 24 (2023) Nr. 6, S. 597 - 610Online Volltext: dx.doi.org/
-
Correction: Individualized treatment of differentiated thyroid cancer : The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear MedicineIn: Nuklearmedizin = Nuclear Medicine (2022) in pressOnline Volltext: dx.doi.org/
-
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI) : A Single-Center Prospective Two-Arm StudyIn: Clinical Cancer Research Jg. 28 (2022) Nr. 19, S. 4194 - 4202Online Volltext: dx.doi.org/ (Open Access)
-
Individualized treatment of differentiated thyroid cancer : The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear MedicineIn: Nuklearmedizin = Nuclear Medicine Jg. 61 (2022) Nr. 02, S. 87 - 96Online Volltext: dx.doi.org/ (Open Access)
-
Intra-therapeutic dosimetry of [¹⁷⁷Lu]Lu-PSMA-617 in low-volume hormone-sensitive metastatic prostate cancer patients and correlation with treatment outcomeIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. 2, S. 460 - 469Online Volltext: dx.doi.org/ (Open Access)
-
[⁶⁸Ga]Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [¹⁷⁷Lu]Lu-PSMA-617 treatmentIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) S. 1101 - 1112Online Volltext: dx.doi.org/ (Open Access)
-
Current treatment strategies in metastasized differentiated thyroid cancerIn: Journal of Nuclear Medicine (JNM) Jg. 60 (2019) Nr. 1, S. 9 - 15Online Volltext: dx.doi.org/ (Open Access)
-
The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancerIn: The Quarterly Journal of Nuclear Medicine and Molecular Imaging Jg. 63 (2019) Nr. 3, S. 235 - 252Online Volltext: dx.doi.org/
-
¹²⁴ J/¹³¹ J-Theranostik des Natrium-Jodid-Symporters beim SchilddrüsenkarzinomIn: TumorDiagnostik & Therapie Jg. 40 (2019) Nr. 8, S. 531 - 536Online Volltext: dx.doi.org/
-
Pretherapeutic 124 i dosimetry reliably predicts intratherapeutic blood kinetics of 131 i in patients with differentiated thyroid carcinoma receiving high therapeutic activitiesIn: Nuclear Medicine Communications Jg. 39 (2018) Nr. 5, S. 457 - 464Online Volltext: dx.doi.org/
-
Quantitative performance of ¹²⁴I PET/MR of neck lesions in thyroid cancer patients using ¹²⁴I PET/CT as referenceIn: EJNMMI Physics Jg. 5 (2018) Nr. 1, 13Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Somatostatinrezeptor-PET/CT : Stand: 3/2017 - AWMF-Registernummer: 031-046In: Nuklearmedizin = Nuclear Medicine Jg. 57 (2018) Nr. 1, S. 4 - 17Online Volltext: dx.doi.org/ (Open Access)
-
Diagnostic accuracy of 18F–FDG PET/CT and MR imaging in patients with adenoid cystic carcinomaIn: BMC Cancer Jg. 17 (2017) Nr. 1, S. 887Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Iodine symporter targeting with 124I/131I theranosticsIn: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. Suppl. 2, S. 34S - 38SOnline Volltext: dx.doi.org/
-
Evaluation of 18F-FDG PET/MRI, 18F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancerIn: European Journal of Radiology Jg. 85 (2016) Nr. 2, S. 459 - 465Online Volltext: dx.doi.org/
-
Serum Thyroglobulin Doubling Time in Progressive Thyroid CancerIn: Thyroid Jg. 26 (2016) Nr. 12, S. 1712 - 1718Online Volltext: dx.doi.org/
-
Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodineIn: The Journal of Clinical Investigation (JCI) Jg. 126 (2016) Nr. 11, S. 4119 - 4124Online Volltext: dx.doi.org/
-
Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients : An ¹⁸F-FDG PET StudyIn: Journal of Nuclear Medicine (JNM) Jg. 56 (2015) Nr. 5, S. 662 - 667Online Volltext: dx.doi.org/ (Open Access)
-
Ethnicity, clothing style, and body mass index are significant predictors of vitamin D insufficiency in GermanyIn: Endocrine Practice Jg. 21 (2015) Nr. 2, S. 122 - 127Online Volltext: dx.doi.org/
-
Impact of dual-energy CT prior to radioembolization (RE)In: Acta Radiologica Jg. 56 (2015) Nr. 11, S. 1293 - 1299Online Volltext: dx.doi.org/
-
Peptidrezeptor-Radionuklidtherapie Somatostatinrezeptor-exprimierender TumoreIn: Nuklearmedizin = Nuclear Medicine Jg. 54 (2015) Nr. 1, S. 1 - 11Online Volltext: dx.doi.org/
-
Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer : A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance ImagingIn: Investigative Radiology Jg. 50 (2015) Nr. 8, S. 505 - 513Online Volltext: dx.doi.org/
-
Accurate assessment of long-term nephrotoxicity after peptide receptor radionuclide therapy with 177Lu-octreotateIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 41 (2014) Nr. 3, S. 505 - 510Online Volltext: dx.doi.org/
-
Anti-Mullerian Hormone : an indicator for the severity of polycystic ovarian syndromeIn: Archives of Gynecology and Obstetrics Jg. 290 (2014) Nr. 5, S. 1023 - 1030Online Volltext: dx.doi.org/
-
Assessment of Lesion Response in the Initial Radioiodine Treatment of Differentiated Thyroid Cancer Using 124I PET ImagingIn: Journal of Nuclear Medicine (JNM) Jg. 55 (2014) Nr. 11, S. 1759 - 1765Online Volltext: dx.doi.org/ (Open Access)
-
Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy 124I PET/CT imagingIn: EJNMMI Physics Jg. 1 (2014) Nr. 1, 100Online Volltext: dx.doi.org/ (Open Access)
-
Combined PET Imaging and Diffusion-Weighted Imaging of Intermediate and High-Risk Primary Prostate Carcinomas with Simultaneous [18F] Choline PET/MRIIn: PLoS ONE Jg. 9 (2014) Nr. 7, S. 0101571Online Volltext: dx.doi.org/ (Open Access)
-
Diagnosis of hyperfunctional thyroidn odules : Impact of US-elastographyIn: Nuklearmedizin = Nuclear Medicine Jg. 53 (2014) Nr. 5, S. 173 - 177Online Volltext: dx.doi.org/
-
Evaluation of the PET component of simultaneous [(18)F]choline PET/MRI in prostate cancer : comparison with [(18)F]choline PET/CTIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 41 (2014) Nr. 1, S. 79 - 88Online Volltext: dx.doi.org/
-
Phase i study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumorsIn: British Journal of Cancer (BJC) Jg. 110 (2014) Nr. 5, S. 1155 - 1162Online Volltext: dx.doi.org/ (Open Access)
-
Prognostic stratification of metastatic gastroenteropancreatic neuroendocrine neoplasms by 18F-FDG PET : Feasibility of a metabolic grading systemIn: Journal of Nuclear Medicine (JNM) Jg. 55 (2014) Nr. 8, S. 1260 - 1266Online Volltext: dx.doi.org/ (Open Access)
-
Quantitative evaluation of bone metastases from prostate cancer with simultaneous [18F] choline PET/MRI : combined SUV and ADC analysisIn: Annals of Nuclear Medicine Jg. 28 (2014) Nr. 5, S. 405 - 410Online Volltext: dx.doi.org/
-
18FDG-PET to assess recurrence and long term survival in patients with malignant melanomaIn: Nuklearmedizin = Nuclear Medicine Jg. 52 (2013) Nr. 5, S. 198 - 203Online Volltext: dx.doi.org/
-
Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions? : Insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumorsIn: EJNMMI Research Jg. 3 (2013) Nr. 1, 82Online Volltext: dx.doi.org/ (Open Access)
-
Spatial reconstruction of human thyroid based on ultrasound and CT image data fusionIn: Biomedical engineering = Biomedizinische Technik Jg. 58 (2013) Nr. Suppl.1,Online Volltext: dx.doi.org/
-
124I-PET/CT images of differentiated thyroid cancer patients : Distinguishing lymph node metastases from thyroid remnants using kinetic quantitiesIn: Nuklearmedizin = Nuclear Medicine Jg. 51 (2012) Nr. 6, S. 213 - 216Online Volltext: dx.doi.org/
-
Assay-Abhängigkeit der Calcitonin- Zielbereiche für „biochemisch geheilte“ Patienten mit medullärem SchilddrüsenkarzinomIn: Nuklearmedizin = Nuclear Medicine Jg. 51 (2012) Nr. 4, S. 125 - 132Online Volltext: dx.doi.org/
-
Differences in the biologic activity of 2 novel MEK inhibitors revealed by¹⁸F-FDG PET: Analysis of imaging data from 2 phase I trialsIn: Journal of Nuclear Medicine (JNM) Jg. 53 (2012) Nr. 12, S. 1836 - 1846Online Volltext: dx.doi.org/
-
Effects of rosiglitazone on radioiodine negative and progressive differentiated thyroid carcinoma as assessed by 124I PET/CT imagingIn: Clinical Nuclear Medicine Jg. 37 (2012) Nr. 3,Online Volltext: dx.doi.org/
-
Estimation of tumour mass in patients with differentiated thyroid carcinoma using serum thyroglobulinIn: Nuklearmedizin = Nuclear Medicine Jg. 51 (2012) Nr. 6, S. 217 - 222Online Volltext: dx.doi.org/
-
F-fluoride PET/CT for bone scanning, Role of attenuation correctionIn: Nuklearmedizin = Nuclear Medicine Jg. 51 (2012) Nr. 3, S. 84 - 87Online Volltext: dx.doi.org/
-
Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinomaIn: Clinical Nuclear Medicine Jg. 37 (2012) Nr. 2, S. 121 - 127Online Volltext: dx.doi.org/
-
Long-term hematotoxicity after peptide receptor radionuclide therapy with 177Lu-octrotateIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 39 (2012) Nr. Suppl. 2, S. 233
-
Phase I trial of panobinostat (P) and imatinib (IM) in patients with treatment-refractory gastrointestinal stromal tumors (GIST)In: Journal of Clinical Oncology (JCO) Jg. 30 (2012) Nr. Suppl. 15, S. 10032
-
Pioglitazone therapy in progressive differentiated thyroid carcinomaIn: Nuklearmedizin = Nuclear Medicine Jg. 51 (2012) Nr. 4, S. 111 - 115Online Volltext: dx.doi.org/
-
Pre-therapeutic blood dosimetry in patients with differentiated thyroid carcinoma using 124-iodine : Predicted blood doses correlate with changes in blood cell counts after radioiodine therapy and depend on modes of TSH stimulation and number of preceding radioiodine therapiesIn: Annals of Nuclear Medicine Jg. 26 (2012) Nr. 9, S. 723 - 729Online Volltext: dx.doi.org/
-
Success rate of repeated fine needle aspiration biopsy of clinically suspicious thyroid nodulesIn: Nuklearmedizin = Nuclear Medicine Jg. 51 (2012) Nr. 4, S. 116 - 118Online Volltext: dx.doi.org/
-
Ultrasound-guided fine-needle aspiration biopsy of clinically suspicious thyroid nodules with an automatic aspirator : A novel techniqueIn: Thyroid Jg. 22 (2012) Nr. 7, S. 695 - 698Online Volltext: dx.doi.org/
-
Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patientsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 39 (2012) Nr. 5, S. 852 - 863Online Volltext: dx.doi.org/
-
Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancerIn: Acta Radiologica Jg. 52 (2011) Nr. 9, S. 1009 - 1014Online Volltext: dx.doi.org/
-
Diagnosis and dosimetry in differentiated thyroid carcinoma using ¹²⁴I PET : Comparison of PET/MRI vs PET/CT of the neckIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 38 (2011) Nr. 10, S. 1862 - 1868Online Volltext: dx.doi.org/
-
Optimierung der Schilddrüsen- Feinnadelpunktion : Automatischer Mikroaspirator versus manuelle TechnikIn: Nuklearmedizin = Nuclear Medicine Jg. 50 (2011) Nr. 5, S. 189 - 194Online Volltext: dx.doi.org/
-
Time course of tumor SUV in¹⁸F-FDG PET of breast cancer: Presentation of a simple model using a single reference point for time corrections of tumor SUVsIn: Journal of Nuclear Medicine (JNM) Jg. 52 (2011) Nr. 1, S. 18 - 23Online Volltext: dx.doi.org/
-
Health-related quality of life and pain in a phase 3 study of [177Lu]Lu-PSMA-617 in taxane-naïve patients with metastatic castration-resistant prostate cancer (PSMAfore)In: Journal of Clinical Oncology (JCO) Jg. 42 (2024) Nr. Suppl. 16, 5003Online Volltext: dx.doi.org/
-
Health-related quality of life (HRQoL), pain and safety outcomes in the phase 3 VISION study of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S55 - S56Online Volltext: dx.doi.org/ (Open Access) -
VISION read criteria of 68Ga-PSMA-11 PET scans for patient eligibility to 177Lu-PSMA-617 therapy : a simple and reproducible methodology
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S129 - S130Online Volltext: dx.doi.org/ (Open Access) -
Health-related quality of life (HRQoL), pain and safety outcomes in the phase III VISION study of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancerIn: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 627 - S628Online Volltext: dx.doi.org/ (Open Access)
-
BRAF Mutation Analysis for Initial Risk Stratification in High Risk Papillary Thyroid CarcinomaIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 551Online Volltext: dx.doi.org/ (Open Access)
-
Comparison of 18F-FDG-PET/MRI and 18F-FDG-PET/CT for initial staging in pulmonary carcinoma
28th Annual EANM Congress of the European Association of Nuclear Medicine, 10-14 October 2015, Hamburg, Germany,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 42 (2015) Nr. Suppl. 1, S. S439 - S440Online Volltext: dx.doi.org/ -
Safety and efficacy of selective internal radiotherapy with Y-90 glass-microspheres in patients with progressive hepatocellular carcinoma (HCC) after failure of transarterial chemoembolization (TACE)
28th Annual EANM Congress of the European Association of Nuclear Medicine, 10-14 October 2015, Hamburg, Germany,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 42 (2015) Nr. Suppl. 1, S. 748Online Volltext: dx.doi.org/ -
Does polymorphism of the glucose transporter-1 gene (GLUT1) modulate (18)FDG uptake and tumor aggressiveness in breast cancer?In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 37 (2010) Nr. Suppl. 2, S. 246Online Volltext: dx.doi.org/
-
PET imaging in thyroid cancerIn: Nuclear Medicine and Molecular Imaging: Volume 3: PET studies / Signore, Alberto; Macapinlac, Homer; Treglia, Giorgio (Hrsg.) 2022, S. 99 - 104Online Volltext: dx.doi.org/
-
Fusion von Szintigrafie und CT für die SchilddrüsendiagnostikIn: Bildverarbeitung für die Medizin 2013: Algorithmen - Systeme - Anwendungen / Meinzer, Hans-Peter; Proceedings des Workshops vom 3. bis 5. März 2013 in Heidelberg 2013, S. 223 - 228Online Volltext: dx.doi.org/
-
Imaging of neuroendocrine tumors with SPECTIn: SPECT: Technology, Procedures and Applications / Ahmadzadehfar, Hojjat; Habibi, Elham (Hrsg.) 2013
-
Tumor imaging with 123/131I-MIBG SPECTIn: SPECT: Technology, Procedures and Applications / Ahmadzadehfar, Hojjat; Habibi, Elham (Hrsg.) 2013
-
Glucose Transporter 1 Express, Tumor Proliferation, and lodine/Glucose Uptake in Thyroid Cancer With Enphasis on Poorly Differented Thyroid CarcinomaDuisburg, Essen (2012) 1 CD-ROM
-
124-I-Dosimetrie für Läsionen kleiner als 1 cm bei Patienten mit differenziertem Schilddrüsen-Karzinom : Phantomstudie und klinischer Vergleich Positronen-Emissions-Tomographie (PET)/Computertomographie (CT) versus PET-Magnetrsonanz-Tomographie (MRT)Duisburg, Essen (2010) 78 Bl. : Ill., graph. Darst.
-
Lack of Somatostatin Receptor Subtype-2 (SSTR2) in the Normal Human Thyroid Gland at Protein Level : Apparent Discrepancy of Immunohistochemistry and Gender-Specific Uptake of 68Ga-DOTATOC?
27th Annual Congress of the European Association of Nuclear Medicine, October 18–22, 2014, Gothenburg, Sweden,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 41 (2014) Nr. Suppl. 2, S. S411Online Volltext: dx.doi.org/